Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Videos [2358]
News [4933]
Articles [204]
Editorials [8]
Conferences [138]
elearning [14]
ASCO GI 2022: Durvalumab plus tremelimumab significantly improves survival for patients with advanced liver cancer compared to sorafenib
ASCO GI 2022: Durvalumab plus tremelimumab significantly improves survival for patients with advanced liver cancer...
ASCO GI 2022: Durvalumab significantly improves survival for patients with biliary tract cancer compared to chemotherapy alone
ASCO GI 2022: Durvalumab significantly improves survival for patients with biliary tract cancer compared to...
ASCO GI 2022: Pembrolizumab significantly improved OS versus placebo in certain patients with advanced HCC previously treated with sorafenib
ASCO GI 2022: Pembrolizumab significantly improved OS versus placebo in certain patients with advanced HCC...
Combination therapies may improve outcomes due to independent, rather than synergistic or additive, drug action
Combination therapies may improve outcomes due to independent, rather than synergistic or additive, drug action
Immunotherapy before liver cancer surgery can kill tumour, and likely residual cancer cells
Immunotherapy before liver cancer surgery can kill tumour, and likely residual cancer cells
Researchers show increased survival rate in prostate cancer patients with addition of hormone therapy treatments
Researchers show increased survival rate in prostate cancer patients with addition of hormone therapy treatments
Matched targeted treatment based on ESCAT actionable genomic alterations associates with improved prognosis of cholangiocarcinoma patients
Matched targeted treatment based on ESCAT actionable genomic alterations associates with improved prognosis of...
Identification of a novel therapeutic target in multiple myeloma
Identification of a novel therapeutic target in multiple myeloma
New research raises awareness of the dangers of septic shock in blood cancer patients in USA
New research raises awareness of the dangers of septic shock in blood cancer patients in USA
Researchers identifies new drug combo for liver cancer via CRISPR-Cas9 screen
Researchers identifies new drug combo for liver cancer via CRISPR-Cas9 screen

More from ecancer

Register with ecancer to receive our newsletter

Register here

Explore patient resources at ecancerpatient

Visit site

Find out more about ecancer and the work we do

About ecancer

Support ecancer's work by making a donation